Physician

Neeharika Muddana, M.D.

According to 2025 Medicare claims, Neeharika Muddana, M.D. (NPI: 1649448911) practices hospitalist in the Parkersburg-Vienna, WV market, with the plurality of this provider's patient population coming from Wood, WV. This provider's primary affiliated billing organization is CAMDEN-CLARK PHYSICIAN CORPORATION (NPI: 1710125430; TIN: 264058719) and primary practice location at 26105-4000. Muddana is affiliated with the ACO West Virginia (ACO ID: A3563) and Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Muddana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 578 traditional Medicare patients, billed 1,813 HCPCS/CPT codes, and received $160,610 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,212 prescription claims across 555 beneficiaries totaling $780,331 in drug costs, led by Jynarque (Tolvaptan). DME data shows 41 claims. Open Payments data shows 14 records totaling $235. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $306,952 to $160,610. In contrast, Part D prescription costs have moved sharply higher in recent years, from $125,204 to $780,331. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $15,069 and ending at $13,878.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	549	85,811	$306,952
2016	330	14,651	$74,041
2017	541	1,804	$143,968
2018	608	1,891	$122,326
2019	528	2,015	$137,526
2020	423	1,625	$122,278
2021	285	896	$67,575
2022	412	1,470	$110,452
2023	520	1,683	$138,017
2024	578	1,813	$160,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	1,594	$125,204
2016	273	991	$86,640
2017	174	441	$21,021
2018	136	292	$15,146
2019	87	195	$9,833
2020	65	183	$10,570
2021	36	92	$6,913
2022	201	781	$93,654
2023	414	2,113	$417,837
2024	555	3,212	$780,331

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	36	$1,721
2017	23	153	$21,277
2018	N/R	138	$23,202
2019	N/R	62	$14,061
2020	N/R	117	$17,997
2021	N/R	63	$3,543
2022	N/R	68	$4,543
2023	N/R	55	$14,136
2024	N/R	41	$13,577

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	111	114	$137
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	122	122	$119
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	115	253	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	289	690	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	182	469	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jynarque	Tolvaptan	13	364	$251,027
Farxiga	Dapagliflozin Propanediol	229	11,874	$210,154
Jardiance	Empagliflozin	177	8,910	$169,982
Veltassa	Patiromer Calcium Sorbitex	52	1,780	$30,383
Kerendia	Finerenone	26	1,080	$22,546

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,052
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$1,289
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	14	$237

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$235	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Neeharika Muddana, M.D.?

Tedicare shows public-source Medicare data for Neeharika Muddana, M.D. (NPI 1649448911), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neeharika Muddana, M.D. have ACO affiliation data?

Neeharika Muddana, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to Neeharika Muddana, M.D.?

Neeharika Muddana, M.D. is linked to CAMDEN-CLARK PHYSICIAN CORPORATION (billing NPI 1710125430) in the available physician profile data.

Does Neeharika Muddana, M.D. have Open Payments data?

Neeharika Muddana, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.